57 related articles for article (PubMed ID: 38506898)
41. LHPP suppresses bladder cancer cell proliferation and growth via inactivating AKT/p65 signaling pathway.
Li Y; Zhang X; Zhou X; Zhang X
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31262971
[TBL] [Abstract][Full Text] [Related]
42. Prognostic implication of adjuvant/neoadjuvant chemotherapy consisting of doxorubicin and ifosfamide in patients with extraskeletal osteosarcoma.
Wakamatsu T; Kakunaga S; Takenaka S; Outani H; Hamada K; Imura Y; Hori Y; Naka N; Kudawara I; Yoshikawa H; Ueda T
Int J Clin Oncol; 2019 Oct; 24(10):1311-1319. PubMed ID: 31197555
[TBL] [Abstract][Full Text] [Related]
43. Targeted nanoparticle-mediated LHPP for melanoma treatment.
Zhang Q; Xiong M; Liu J; Wang S; Du T; Kang T; Liu Y; Cheng H; Huang M; Gou M
Int J Nanomedicine; 2019; 14():3455-3468. PubMed ID: 31190803
[No Abstract] [Full Text] [Related]
44. COX6A2 variants cause a muscle-specific cytochrome c oxidase deficiency.
Inoue M; Uchino S; Iida A; Noguchi S; Hayashi S; Takahashi T; Fujii K; Komaki H; Takeshita E; Nonaka I; Okada Y; Yoshizawa T; Van Lommel L; Schuit F; Goto YI; Mimaki M; Nishino I
Ann Neurol; 2019 Aug; 86(2):193-202. PubMed ID: 31155743
[TBL] [Abstract][Full Text] [Related]
45. TMEM9 promotes intestinal tumorigenesis through vacuolar-ATPase-activated Wnt/β-catenin signalling.
Jung YS; Jun S; Kim MJ; Lee SH; Suh HN; Lien EM; Jung HY; Lee S; Zhang J; Yang JI; Ji H; Wu JY; Wang W; Miller RK; Chen J; McCrea PD; Kopetz S; Park JI
Nat Cell Biol; 2018 Dec; 20(12):1421-1433. PubMed ID: 30374053
[TBL] [Abstract][Full Text] [Related]
46. Understanding osteosarcomas.
Simpson E; Brown HL
JAAPA; 2018 Aug; 31(8):15-19. PubMed ID: 29979330
[TBL] [Abstract][Full Text] [Related]
47. Histopathologic Features of Prognostic Significance in High-Grade Osteosarcoma.
Chui MH; Kandel RA; Wong M; Griffin AM; Bell RS; Blackstein ME; Wunder JS; Dickson BC
Arch Pathol Lab Med; 2016 Nov; 140(11):1231-1242. PubMed ID: 27552092
[TBL] [Abstract][Full Text] [Related]
48. Tumor microenvironment and therapeutic response.
Wu T; Dai Y
Cancer Lett; 2017 Feb; 387():61-68. PubMed ID: 26845449
[TBL] [Abstract][Full Text] [Related]
49. Down-Regulation of NDUFB9 Promotes Breast Cancer Cell Proliferation, Metastasis by Mediating Mitochondrial Metabolism.
Li LD; Sun HF; Liu XX; Gao SP; Jiang HL; Hu X; Jin W
PLoS One; 2015; 10(12):e0144441. PubMed ID: 26641458
[TBL] [Abstract][Full Text] [Related]
50. Mutation screening of 75 candidate genes in 152 complex I deficiency cases identifies pathogenic variants in 16 genes including NDUFB9.
Haack TB; Madignier F; Herzer M; Lamantea E; Danhauser K; Invernizzi F; Koch J; Freitag M; Drost R; Hillier I; Haberberger B; Mayr JA; Ahting U; Tiranti V; Rötig A; Iuso A; Horvath R; Tesarova M; Baric I; Uziel G; Rolinski B; Sperl W; Meitinger T; Zeviani M; Freisinger P; Prokisch H
J Med Genet; 2012 Feb; 49(2):83-9. PubMed ID: 22200994
[TBL] [Abstract][Full Text] [Related]
51. Osteosarcoma.
Ritter J; Bielack SS
Ann Oncol; 2010 Oct; 21 Suppl 7():vii320-5. PubMed ID: 20943636
[TBL] [Abstract][Full Text] [Related]
52. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.
Ferrari S; Smeland S; Mercuri M; Bertoni F; Longhi A; Ruggieri P; Alvegard TA; Picci P; Capanna R; Bernini G; Müller C; Tienghi A; Wiebe T; Comandone A; Böhling T; Del Prever AB; Brosjö O; Bacci G; Saeter G;
J Clin Oncol; 2005 Dec; 23(34):8845-52. PubMed ID: 16246977
[TBL] [Abstract][Full Text] [Related]
53. On the origin of cancer cells.
WARBURG O
Science; 1956 Feb; 123(3191):309-14. PubMed ID: 13298683
[No Abstract] [Full Text] [Related]
54. Human NDUFB9 gene: genomic organization and a possible candidate gene associated with deafness disorder mapped to chromosome 8q13.
Lin X; Wells DE; Kimberling WJ; Kumar S
Hum Hered; 1999 Mar; 49(2):75-80. PubMed ID: 10077726
[TBL] [Abstract][Full Text] [Related]
55. Construction of an oxidative phosphorylation-related gene signature for predicting prognosis and identifying immune infiltration in osteosarcoma.
Zhou P; Zhang J; Feng J; Wang G
Aging (Albany NY); 2024 Mar; 16(6):5311-5335. PubMed ID: 38506898
[TBL] [Abstract][Full Text] [Related]
56. Signature constructed by glycolysis-immune-related genes can predict the prognosis of osteosarcoma patients.
Tian K; Qi W; Yan Q; Lv M; Song D
Invest New Drugs; 2022 Aug; 40(4):818-830. PubMed ID: 35435626
[TBL] [Abstract][Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
